Perception and preferences regarding COVID-19 vaccines in residents of a northern Peruvian city, 2021

Authors

  • Julio Cjuno
  • Edgard Bazan Palomino
  • Rodolfo González Ramírez
  • Roxy Polo Bardales.
  • Marco Alvarado Carbonel
  • Miguel Ipanaque Zapata
  • Ronald M. Hernández

Keywords:

COVID-19, SARS-CoV-2, COVID-19 Vaccines (Mesh)

Abstract

INTRODUCTION: Given the high probability of serious illness and mortality from COVID-19 and a delay in the vaccination process in Peru, it is important to know the perception and preferences regarding the available vaccines.

OBJECTIVE: Describe the perception and preferences about vaccines for COVID-19 in residents of a city in northern Peru, 2021.

MATERIAL AND METHODS: Cross-sectional study, with a sample of (n = 741) inhabitants of the city of Piura Peru in the period May and June 2021, of which 474 (64.0%) were young and 267 (36.0%) were adults. the majority 452 (61.0%) were female, 578 (78.0%). Using an instrument created for this purpose, which was validated by judges and residents of Piura in focus groups.

RESULTS: The majority 717 (96.8%) prefer a specific vaccine, being the preferred vaccines from Pfizer (39.68%) and Sinopharm (23.35%). Also, 571 (77.1%) have the expectation that the vaccine will help prevent COVID-19 infection. On the other hand, 426 (89.9%) participants aged between 18 to 26 years (p = 0.005) and 239 (90.9%) dependent workers (p = 0.009) who claim to perceive that the side effects of vaccines are mild. Finally, due to the risk of death, 177 (37.3%) participants aged 18 to 26 years (p = 0.000), 164 (49.0%) participants who live in urbanizations (p = 0.002) and 132 (50.2%) dependent workers (p = 0.000) are looking to get vaccinated on their own.

CONCLUSIONS: Most prefer a specific vaccine according to its efficacy and side effects; For this reason, it is important to carry out efficient dissemination campaigns on vaccines that could be the support of public figures. On the other hand, citizens are waiting their turn to be vaccinated, but there is a significant percentage of the population that is seeking to be vaccinated by other means.

Downloads

Download data is not yet available.

References

Organización Mundial de la Salud. Información básica sobre la COVID-19 [Internet]. 2021 [citado 4 de julio de 2021]. Disponible en: https://www.who.int/es/news-room/q-a-detail/coronavirus-disease-covid-19

Ministerio de Salud. Primer caso de coronavirus en Perú se dio en un joven procedente de Europa, confirma Martín Vizcarra [Internet]. CDC MINSA. [citado 4 de julio de 2021]. Disponible en: https://www.dge.gob.pe/portalnuevo/informativo/vigilancia-de-rumores/reporte030-2020/

Ministerio de Salud. Sala situacional COVID-19 Perú [Internet]. 2021 [citado 4 de julio de 2021]. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp

Ministerio de Salud. Coronavirus: variantes de la COVID-19 detectadas en el Perú [Internet]. 2021 [citado 4 de julio de 2021]. Disponible en: https://www.gob.pe/12548-coronavirus-variantes-de-la-covid-19-detectadas-en-el-peru

World Health Organization. The Sinopharm COVID-19 vaccine: What you need to know [Internet]. [citado 27 de julio de 2021]. Disponible en: https://www.who.int/news-room/feature-stories/detail/the-sinopharm-covid-19-vaccine-what-you-need-to-know

Ministry of Helath. COVID-19: Vaccine effectiveness and protection [Internet]. Ministry of Health NZ. [citado 27 de julio de 2021]. Disponible en: https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccine-effectiveness-and-protection

Knoll MD, Wonodi C. Oxford–AstraZeneca COVID-19 vaccine efficacy. The Lancet. 9 de enero de 2021;397(10269):72-4.

Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. septiembre de 2020;26:100495.

Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 27 de agosto de 2020;8(3):482.

Palamenghi L, Barello S, Boccia S, Graffigna G. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol. 17 de agosto de 2020;1-4.

Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines. 14 de abril de 2021;9(4):382.

Qiao S, Friedman DB, Tam CC, Zeng C, Li X. Vaccine acceptance among college students in South Carolina: Do information sources and trust in information make a difference? MedRxiv Prepr Serv Health Sci. 4 de diciembre de 2020;2020.12.02.20242982.

Southwell BG, Kelly BJ, Bann CM, Squiers LB, Ray SE, McCormack LA. Mental Models of Infectious Diseases and Public Understanding of COVID-19 Prevention. Health Commun. diciembre de 2020;35(14):1707-10.

Preguntas y respuestas sobre la enfermedad por coronavirus (COVID-19) [Internet]. 2021 [citado 4 de julio de 2021]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses

Asociación Médica Mundial. Declaración de Helsinki [Internet]. 2018 [citado 21 de mayo de 2021]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

Fares S, Elmnyer MM, Mohamed SS, Elsayed R. COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt. J Prim Care Community Health. 29 de abril de 2021;12:21501327211013304.

Bokemper SE, Huber GA, Gerber AS, James EK, Omer SB. Timing of COVID-19 vaccine approval and endorsement by public figures. Vaccine. 29 de enero de 2021;39(5):825-9.

Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. diciembre de 2020;14(12):e0008961.

Tsai F-J, Yang H-W, Lin C-P, Liu JZ. Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19. Int J Environ Res Public Health. 23 de mayo de 2021;18(11):5579.

Organización Panamericana de la Salud, Organización Mundial de la Salud. Vacunas contra la COVID-19 [Internet]. 2021 [citado 3 de julio de 2021]. Disponible en: https://www.paho.org/es/vacunas-contra-covid-19

Organización Mundial de la Salud. Influencia de la pobreza en la salud [Internet]. WHO; 2003. Report No.: 113. Disponible en: https://apps.who.int/gb/ebwha/pdf_files/EB113/seb11312.pdf

Abdelhafiz AS, Mohammed Z, Ibrahim ME, Ziady HH, Alorabi M, Ayyad M, et al. Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19). J Community Health. 21 de abril de 2020;1-10.

Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, et al. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 1 de abril de 2021;39(14):1968-76.

Published

2023-04-11

How to Cite

Julio Cjuno, Edgard Bazan Palomino, Rodolfo González Ramírez, Roxy Polo Bardales., Marco Alvarado Carbonel, Miguel Ipanaque Zapata, & Ronald M. Hernández. (2023). Perception and preferences regarding COVID-19 vaccines in residents of a northern Peruvian city, 2021. AVFT – Archivos Venezolanos De Farmacología Y Terapéutica, 40(7). Retrieved from http://saber.ucv.ve/ojs/index.php/rev_aavft/article/view/26083